Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Brachial Plexopathy Localization in Patients with Cancer
    ABSTRACT & COMMENTARY

    Brachial Plexopathy Localization in Patients with Cancer

    August 1, 2020
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Brachial Plexopathy: Patterns and Pathogenesis

    EMG for Sacral Plexopathy

    MRI of the Brachial and Lumbar Plexus Assists in the Diagnosis of CIDP

    Related Products

    Alzheimer’s Disease: What the Primary Care Physician Needs to Know

    All Access Subscription: Online

    Keywords

    imaging

    radiation

    brachial

    plexus

    plexopathy

    trunk

    By Michael Rubin, MD

    Professor of Clinical Neurology, Weill Cornell Medical College

    Dr. Rubin reports he is a consultant for Merck Sharp & Dohme Corp.

    SYNOPSIS: Brachial plexopathy associated with cancer may involve any region of the brachial plexus and can be distinguished from radiation-induced brachial plexopathy only by the use of high-resolution magnetic resonance imaging.

    SOURCE: McNeish BL, Zheutlin AR, Richardson JK, Smith SR. Primary cancer location predicts predominant level of brachial plexopathy. Muscle Nerve 2020; June 8. doi:10.1002/mus.26994. [Online ahead of print].

    Shoulder and axillary pain are the most common presenting symptoms of neoplastic-induced brachial plexopathy (NIBP). Involvement of the inferior trunk is more common than that of the upper trunk, and breast and lung cancer are the most frequent neoplasms. Distinguishing cancer recurrence from radiation-induced brachial plexopathy (RIBP) can be challenging. Horner syndrome, pain at symptom onset, and lower plexus involvement traditionally are more likely in NIBP, whereas RIBP often is painless early on, is associated with more severe paresthesiae and weakness than NIBP, and tends to affect the upper trunk. In the era of computer-guided radiation dosing, targeting, and delivery, is this traditional approach to causation and localization still correct?

    In this retrospective electronic medical record review, researchers analyzed all nerve conduction (NCS) and needle electromyography (EMG) studies performed at The Michigan Medicine Electrodiagnostic Laboratory in Ann Arbor from January 2008 through January 2019 and coded for brachial plexopathy. Collated information included age, gender, cancer type, clinical symptoms, radiation history, imaging information, and NCS/EMG findings. Inclusionary criteria required presenting symptoms consistent with brachial plexopathy in a patient with a history of cancer and radiation therapy. Patients with a history suggesting trauma or neuralgic amyotrophy (Parsonage-Turner syndrome) were excluded. NCS required the presence of decreased motor and sensory amplitudes, with abnormal spontaneous activity and high-amplitude, long-duration motor-unit potentials and reduced recruitment on needle EMG study. Spontaneous activity included positive sharp waves, fibrillation potentials, and myokymic discharges. Imaging results indicating the presence or absence of tumor invasion of the plexus and/or adjacent lymph nodes differentiated NIBP from RIBP, respectively. Statistical analysis comprised Student’s t-test, chi-square test, logistic regression, and bivariate analyses, with 0.05 used as the threshold for statistical significance.

    Among 912 cases of brachial plexopathy, 22 were diagnosed as NIBP and 34 as RIBP. NIBP more often presented with pain, but there was no difference between NIBP and RIBP in the distribution of predominant trunk involved. The primary cancer location (superior or inferior to the clavicle) was significantly associated with plexopathy location (upper or lower trunk) in both NIBP (P = 0.047) and RIBP (P = 0.003), and multivariate analysis revealed that the primary cancer location superior or inferior to the clavicle was the strongest predictor of upper or lower trunk involvement, respectively. Infraclavicular tumors (e.g., lung and breast cancers) were highly predictive of predominantly lower trunk plexopathy, whereas supraclavicular tumors (e.g., head and neck cancers) were predictive of upper trunk plexopathy, regardless of whether the injury was related to radiation or neoplastic invasion. As the authors concluded, current high-resolution imaging contradicts the traditional teaching around localization of brachial plexus lesions.

    COMMENTARY

    Other studies report different findings. Among 44 patients with breast cancer seen at the Asian Medical Center in Seoul, South Korea, between 2000 and 2016, of whom 41 were evaluated by EMG, upper trunk involvement of the brachial plexus was most frequent, affecting 22%. Lower trunk involvement was seen in 9.9%. Among 19 patients who underwent magnetic resonance imaging, supraclavicular-region metastases were found in 57.9%. It would appear that metastases from either above or below the clavicle may affect either the upper or lower portions of the brachial plexus. Clinical observation and imaging indicate that any cancer can affect any part of the brachial plexus.1

    REFERENCE

    1. Kim J, Jeon JY, Choi YJ, et al. Characteristics of metastatic brachial plexopathy in patients with breast cancer. Support Care Cancer 2020;28:1913-1918.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert (Vol. 39, No. 12) - August 2020
    August 1, 2020

    Table Of Contents

    Clinical Trials of IL-6 Inhibitors for the Treatment of Neuromyelitis Optica Spectrum Disorders

    Brachial Plexopathy Localization in Patients with Cancer

    Anticoagulation in Patients with Ischemic Stroke Related to Atrial Fibrillation, Following Reperfusion Therapy

    Treatment of Central Retinal Artery Occlusion with Intravenous Thrombolysis

    Widely Used in Asia, Cilostazol Appears Effective for Long-Term Secondary Stroke Prevention

    Should Patients with Ischemic Stroke and Large Vessel Occlusions Go Directly to Endovascular Thrombectomy?

    Mobile Stroke Units: What Is the Best Way to Use Them?

    COVID-19 Infection Increases Stroke Risk by Almost Eight Times the Stroke Risk with Influenza

    Ticagrelor Added to Aspirin Reduces Long-Term Risk of Recurrent Stroke or Death After Ischemic Stroke or TIAs

    We’d Love to Hear from You!

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Morrow Mark; and Accreditations Director Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421 x 2

    International +1-404-262-5476 x 2

    Accounts Receivable

    1-800-688-2421 x 3
    ReliasMedia_AR@reliasmedia.com

    Sales

    1-800-688-2421 x 1

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2022 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing